The invention belongs to the technical field of 
gene vaccines and particularly relates to a 
vibrio mimicus oral target 
epitope gene vaccine. The 
vibrio mimicus oral target 
epitope gene vaccine comprises the following steps: S1, designing a vaccine 
target gene OVepis; S2, inserting the vaccine 
target gene OVepis designed in the S1 into 261-280bp of a related 
peptide fragment area of a II-type molecule in a 
protein coding gene CD74 of an immune carrier 
grass carp, wherein the direction is from 5'end to 3'end of a sequence; forming a CD74(1-261bp)-Ovepis-CD74(280-711bp) mosaic gene of 1020 bp, loading the mosaic gene by using a freeze-
drying bacterial ghost of 
escherichia coli DH5a of a targeted delivery vector, and obtaining the target 
epitope gene vaccine. The 
nucleotide sequence of the mosaic gene is shown in SEQ ID NO:20. The 
vibrio mimicus oral target epitope gene vaccine has the beneficial effects that: the oral target epitope gene vaccine not only prevents the degradation of 
nuclease in vivo and increases the expression of 
a DNA encoding gene of the vaccine in a local 
antigen presenting 
cell of a 
mucous membrane, but also efficiently transfers an expressed and processed antigenpeptide to cells T and B, so that the immune effect of the vaccine is greatly improved.